Victory Capital Management Inc. grew its position in Addus HomeCare Co. (NASDAQ:ADUS – Free Report) by 14.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 96,832 shares of the company’s stock after purchasing an additional 11,872 shares during the period. Victory Capital Management Inc. owned approximately 0.53% of Addus HomeCare worth $12,138,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also modified their holdings of ADUS. Smartleaf Asset Management LLC grew its stake in shares of Addus HomeCare by 324.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 280 shares of the company’s stock valued at $35,000 after buying an additional 214 shares in the last quarter. Parkside Financial Bank & Trust lifted its position in shares of Addus HomeCare by 38.6% during the fourth quarter. Parkside Financial Bank & Trust now owns 531 shares of the company’s stock worth $67,000 after purchasing an additional 148 shares in the last quarter. Proficio Capital Partners LLC acquired a new position in shares of Addus HomeCare during the fourth quarter worth $1,933,000. Oppenheimer & Co. Inc. boosted its stake in shares of Addus HomeCare by 21.0% in the fourth quarter. Oppenheimer & Co. Inc. now owns 6,038 shares of the company’s stock valued at $757,000 after purchasing an additional 1,047 shares during the period. Finally, Illinois Municipal Retirement Fund lifted its holdings in Addus HomeCare by 2.4% in the 4th quarter. Illinois Municipal Retirement Fund now owns 9,657 shares of the company’s stock worth $1,211,000 after buying an additional 223 shares in the last quarter. 95.35% of the stock is owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
Several research analysts recently commented on ADUS shares. StockNews.com cut Addus HomeCare from a “buy” rating to a “hold” rating in a research note on Wednesday, February 26th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $136.00 target price on shares of Addus HomeCare in a research report on Thursday, November 14th. Stephens reissued an “overweight” rating and set a $142.00 price target on shares of Addus HomeCare in a research report on Wednesday. Macquarie reaffirmed an “outperform” rating and issued a $129.00 price target on shares of Addus HomeCare in a report on Thursday, February 27th. Finally, JMP Securities began coverage on shares of Addus HomeCare in a research note on Monday, December 16th. They set an “outperform” rating and a $150.00 price objective on the stock. One equities research analyst has rated the stock with a sell rating, one has given a hold rating, seven have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $132.78.
Addus HomeCare Stock Performance
Shares of NASDAQ:ADUS opened at $90.78 on Friday. The company’s fifty day moving average is $116.65 and its two-hundred day moving average is $123.82. Addus HomeCare Co. has a 1-year low of $87.88 and a 1-year high of $136.72. The stock has a market capitalization of $1.65 billion, a price-to-earnings ratio of 20.77, a price-to-earnings-growth ratio of 1.41 and a beta of 0.97.
Addus HomeCare (NASDAQ:ADUS – Get Free Report) last released its quarterly earnings data on Monday, February 24th. The company reported $1.26 earnings per share for the quarter, missing the consensus estimate of $1.35 by ($0.09). The business had revenue of $297.14 million for the quarter, compared to analyst estimates of $291.04 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. Sell-side analysts expect that Addus HomeCare Co. will post 4.59 EPS for the current fiscal year.
Insider Buying and Selling
In other Addus HomeCare news, CEO R Dirk Allison sold 25,000 shares of the stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $124.76, for a total value of $3,119,000.00. Following the sale, the chief executive officer now directly owns 79,397 shares of the company’s stock, valued at $9,905,569.72. This trade represents a 23.95 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Company insiders own 4.60% of the company’s stock.
Addus HomeCare Profile
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Recommended Stories
- Five stocks we like better than Addus HomeCare
- 5 Top Rated Dividend Stocks to Consider
- 3 Undervalued Stocks You Can Buy at a Discount Now
- Health Care Stocks Explained: Why You Might Want to Invest
- AMD Stock: Can the PC Refresh Cycle Spark a Rally?
- 3 Dividend Kings To Consider
- Micron Stock Spikes 7%—3 Key Catalysts Behind the Move
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.